… Read More

The CMO (contract manufacturing organization) and CDMO (contract development and manufacturing organization) biotechnology market is a rapidly growing industry driven by the increasing deman… Read More

The Global Biologics CDMO Market was valued at USD 9.93 billion and is expected to reach USD 18.63 billion, registering a CAGR of 10.87% during the forecast period.The CMO/CDMO service… Read More

 The biologics safety testing market was valued at USD 2.75 billion in 2022 and is expected to grow at a CAGR of 12.2% to a USD 4.90 billion market by 2031 The biologics safety testi… Read More

Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing ser… Read More

Vaccine Contract ManufacturingContract manufacturing is a complex process involved in producing vaccine products. This type of production usually involves the manufacturing of vaccines in a… Read More

Reports and Data has recently published a new research report on Global Biological Safety Testing Market that covers current development scenario and emerging trends of the market.The resear… Read More

Buy Now Biologics are termed as those product that attained from living organism and feature a differentiate set of properties. The biologics want extreme safety from contamination thus biol… Read More

Biologics are pharmaceutical products that are extracted from biological sources. Biologics safety testing is carried out by manufacturers to detect contaminants like bacterial toxins, mycop… Read More

The size of the Cell Line Development Market was accrued at USD 4.2 billion in 2019 and is presumed to accumulate over USD 9.8 billion by the year 2026. According to research, the Cell Line… Read More

The biologics safety testing market was valued at USD 2.75 Billion in 2017 and is expected to grow at a CAGR of 12.2% to reach USD 4.90 Billion in 2022. Growth in pharmaceutical and biote… Read More

Biopharmaceuticals are biological products which are developed and manufactured for addressing the prevention of and treatment of a variety of diseases. The latest developments in biotechnol… Read More

OKLAHOMA CITY, March 14, 2017 (GLOBE NEWSWIRE) — Cytovance® Biologics, a leading CDMO who provides unparalleled support to biopharmaceutical companies to move candidate molecules f… Read More